Buy & Sell UnitedHealth Group Inc (UNH) – UnitedHealth Group Inc Price Today
Aura AI Summary
Key Stats
- $359.98BMarket Cap
- HealthSector
- -12.18%3M Drawdown
- $406.67BEnterprise Value
- 2.23%Dividend Yield
- 82% Buy | 18% SellTrading Activity
- 88 daysTypical Hold Time
UnitedHealth Group Inc (UNH) is currently valued at a market capitalization of $359.98B, with an enterprise value of $406.67B. Over the past 52 weeks, UnitedHealth Group Inc has traded between a low of $237.77 and a high of $396.39, highlighting its annual price range. Over the past three months, UnitedHealth Group Inc has recorded a drawdown of -12.18%, reflecting recent price volatility. UnitedHealth Group Inc offers a dividend yield of 2.23%, with the most recent dividend of $2.21 paid on 09 Mar 26. On average, investors hold UnitedHealth Group Inc for approximately 88 days, indicating typical investor behavior on the platform.
About UnitedHealth Group Inc
UnitedHealth Group is one of the largest private health insurers, providing medical benefits to 50 million members globally, including 5 million outside the U.S. at the end of 2021. As a leader in employer-sponsored, self-directed, and government-backed insurance plans, UnitedHealth has obtained massive scale in managed care. Along with its insurance assets, UnitedHealth's continued investments in its Optum franchises have created a healthcare services colossus that spans everything from medical and pharmaceutical benefits to providing outpatient care and analytics to both affiliated and third-party customers.
Most Recent News
Digital fraud attempts in Canada exceed global average; median loss per victim is CAD 1,301 in 2025
In 2025, Canada experienced a higher rate of suspected digital fraud attempts (4.4%) compared to the global average (3.8%), with 13% of Canadians reporting financial losses averaging CAD 1,301. Credit card fraud was the most common cause, followed by...
Zymeworks to present at three major investor conferences in May and June 2026
Zymeworks Inc., a biotechnology company, announced its management will participate in three upcoming investor conferences: the Stifel Virtual Targeted Oncology Forum on May 20, the TD Cowen Oncology Innovation Summit on May 27, and the Jefferies Glob...
Tesla drops out of China's top 10 EV makers amid sales decline, launches new affordable financing in China.
Tesla's retail sales in China fell 9% year-over-year in April, dropping the company out of the top 10 electric vehicle makers in the Chinese market. Despite this, Tesla ranked fifth in total sales from January to April 2026 with 138,754 units sold. I...